While we're looking at data, it should be noted that. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines. This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likelyto improve kidney function. If exercised for cash, the warrants would result in additional gross proceeds to Progenity of up to approximately $46 million. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. At the moment and probably for more than a few weeks to come, following this quarters sales miss and ongoing red ink a peek at the rearview mirror in PROG stock and why were even discussing those shares makes sense before making any buy decisions. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosisand has an addressable market in the U.S. of at least $800 million. Any forward-looking statements that Progenity makes in this press release speak only as of the date of this press release. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials. But with revenues plunging and the DoJ news adding more headwinds, Progenity wound down the testing business. A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer's disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19. To make the world smarter, happier, and richer. Progenity has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable in connection with the private placement and upon exercise of the warrants. Progenity is a California-based biotech specializing in precision medicine through in vitro molecular tests to provide patients with actionable information for improved health outcomes.. 5 Hypergrowth Stocks With 10X Potential in 2023, assessment of preeclampsia using assays for free and dissociated placental growth factor., LCID Stock: Why Lucid Shares Are Going in Reverse on Tuesday, Casino Stocks: Why WYNN, LVS, MLCO and MGM Are Taking a Hit Today, LIFE Stock: 7 Things to Know About Biotech aTyr Pharma as Shares Soar on Study Results, How to Tell if an AI Company Is Legit or Selling Snake Oil, Expect the Amazon Stock Slump to Continue, Louis Navellier and the InvestorPlace Research Staff. That would make the most sense incase trials don't go as expected as to not make a partner look bad. Over the last four quarters, the company has beaten consensus EPS estimates two times. It is considered more dangerous because its much more likely to invade nearby tissue and spread to other parts of the body if not caught and treated early when it is most likely to be cured. One in five people will receive a diagnosis of cancer within their lifetime. on March 8th, 1pm MST, for a no-BS, female founder-led, 'behind the curtain' conversation on IG Live @NULASTIN. So whats the outlook for PROG stock as it makes its transition into a biotech company? Larry began writing columns for, in 2015. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later. Copyright The genitourinary (GU) tract is comprised of urinary, reproductive and adrenal system organs. On the other hand, at this point the deck seems to be stacked against unprofitable companies such as Progenity that are likely a few years away from entering the black. Two Wall Street Legends will reveal their #1 recommendations and full "roadmap" for navigating the coming AI revolution. Sign up below to get this incredible offer! Now that they have their last resistance, we can start with the real work from today! OncologyBiology into medicineAdvocacyGlobal Impact. Sorry, you need to enable JavaScript to visit this website. 2023 InvestorPlace Media, LLC. He has been employed by The Fly and Israels largest business newspaper, Globes. The warrants will have a per share exercise price of $2.84 and may be exercised at any time on or after the closing date and through the fifth anniversary of the closing date. Similarly, the merger between Torchlight and Meta Materials (NASDAQ:MMAT) was an absolute mess. But rather than being compelled to appreciate Progenity as one of the next big things on Wall Street, today simply realize its something else entirely. Bottom-line though, if readers see things differently, agreeably please look to hedge whats a much riskier risk-asset with a longer-term bull call spread, stock collar or married put strategy. Among his highlysuccessful, contrarian picks have been Plug Power, solar stocks, and Snap. After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Also encouragingly, dEsparbes sounded very optimistic about data that will be reported in the coming months on OBDS. The automatic dividends accumulate over time. At the time of writing, nearly three times the average daily number of shares have been traded . The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines. What happened. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. Progenity completed its IPO in June 2020. With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Progenity, Inc. (PROG) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ETCompany ParticipantsRobert Uhl - Managing Director, Westwicke ICRDr. With COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. HOUSTON, March 01, 2023--Informative Research (IR), a subsidiary of Stewart Information Services Corporation (NYSE:STC), today announced the acquisition of the AccountChek platform previously offered by FormFree. 1125 N. Charles St, Baltimore, MD 21201. In the immediate aftermath of PROG stocks earnings release shares are off just over 10%. The gross proceeds to Progenity from this offering are expected to be approximately $20 million, before deducting the placement agent's fees and other offering expenses. More than 1 million people worldwide were diagnosed with a blood cancer in 2020, representing almost 6% of all cancer diagnoses globally. Given these points, Progenity appears set to report very strong financial results in several years. Nasdaq Research and Business Development Partnerships. The securities being sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. These risks and uncertainties include, without limitation, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the registered direct offering. All rights reserved. Progenity, Inc. But given Octobers rally and shares as low as 66 cents in late August, Id define it as profit-taking. Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Today, PROG stock has moved more than 15% higher at the time of writing on very heavy volume. progenity @progenity Jan 11 On Feb 9, Dr. Bram Verstockt will be presenting patient data on patient drug levels in the colon at the Belgian Week of Gastroenterology # bwge # IBD 36 replies 33 retweets 168 likes progenity @progenity Jan 10 Our presentation from @ HCWCO Bioconnect 2022 is now available to stream. PROG stock closed yesterday at $2.04. The company tried to soldier on for awhile. And, needless to say, the odds of any early stage drug actually making it through Phase 3 trials and getting Food and Drug Administration (FDA) approval is quite low. An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Find the latest Biora Therapeutics, Inc. (4ZU.F) stock discussion in Yahoo Finance's forum. Lung cancer remains the leading cause of cancer-related death among men and women globally, and the global five-year survival rate at 17.8 percent is much lower than leading cancers. with tofacitinib. Progenity: Dont Bet on This Biotech Firm Yet, 5 Hypergrowth Stocks With 10X Potential in 2023, How to Tell if an AI Company Is Legit or Selling Snake Oil, Expect the Amazon Stock Slump to Continue, Louis Navellier and the InvestorPlace Research Staff. With a huge short interest, there was some trading potential there. " Great benefits." " good people to work with" (in 11 reviews) Cons. On the OBDS front, Progenity is already partnering with three drug makers, including at least one major pharmaceutical company, with which it established an alliance in the third quarter. As a result of earlier screening, increased awareness, and better treatments, breast cancer deaths have continued to decrease in older women. Research Sites Thousands of users reported problems starting around 5:15 a.m. This informationincluding product informationis intended only for residents of the United States. 1125 N. Charles St, Baltimore, MD 21201. Progenity, Inc. (PROG) : Free Stock Analysis Report. Get prepared with the key expectations. While there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. It all happens at the free AI Super Summit. Yet at this point, biologics, including monoclonal antibodies, can only be administered intravenously. Most new drugs fail; it comes with the territory. SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Progenity) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive securities purchase agreement with two leading healthcare-focused investment funds for the sale of units consisting of shares of common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase common stock, as described below, in a private placement expected to result in gross proceeds to Progenity of approximately $40 million, before deducting placement agent commissions and other offering expenses. quotes delayed at least 15 minutes, all others at least 20 minutes. Idont believe that these drug makers would spend valuable time and money to partner with Progenity on OBDS unless it had a very good chance of working well. Two Wall Street Legends will reveal their #1 recommendations and full "roadmap" for navigating the coming AI revolution. We engage in partnerships with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need. What Is the Best Tech Stock to Buy Now? So, this combination indicates that Progenity, Inc. Will most likely beat the consensus EPS estimate. What Is the Best Tech Stock to Buy Now? A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). The aggregate purchase price of each unit, which consists of one share of common stock (or pre-funded warrants in lieu thereof) plus a warrant to purchase one share of common stock, is $2.47. Let's look at three potential candidates that could help Pfizer to further secure its future. Additional information concerning these and other risks can be found in Progenitys periodic filings with the SEC, including under the heading Risk Factors contained therein. This was a rather remarkable turn of events for a company that IPOed just one year ago on the strength of this now-shuttered business. All rights reserved. 16. Still Progenity is unprofitable, and its likely to stay that away for at least two or three years. Progenity had to pay $49 million to settle charges around fraudulent billing and kickbacks. Pfizer has paid Beam. Uncensored. quotes delayed at least 15 minutes, all others at least 20 minutes. Progenity, Inc. is a biotechnology company innovating in the fields of womens health, gastrointestinal health and oral biotherapeutics. The autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. Meme trades based around corporate transitions this year have been a fiasco. Read More: Penny Stocks How to Profit Without Getting Scammed. Others develop in the bones and blood over time, requiring intense and aggressive treatment interventions that are traumatic, emotionally overwhelming, and expensive. The study was small, but it's some of the first data we have on vaccines and male fertility. Pfizer-BioNTech COVID-19 Vaccine is a monovalent COVID-19 vaccine that is authorized for emergency use to prevent COVID-19 as: The first two doses of the three-dose primary series for children 6 . At the time, the company marketed itself as an advanced testing company using genomics, epigenomics, proteomics and metabolomics to improve patient lives. Source: Shutterstock The patent for Progenity is for its " assessment of. Details from major Research & Development locations are listed below. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion. And while PROG stock is a name youre likely to have not crossed paths with, a nearly nine-fold increase in volume totaling more than 3 billion shares indicates others certainly have, and for good reason. Patrick Bafuma has no position in any of the stocks mentioned. The products discussed herein may have different labeling in different countries. Discover something new every day from News, Sports, Finance, Entertainment and more! Altogether, these markets add up to about 6,000 patients annually in the U.S. At a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner Roche will split costs and profits 50-50 in the U.S. Some may see the price action as punitive. The relatives of victims of Sunday's boat wreck off Italy commemorated their loved ones on Wednesday in a sports hall in the Calabrian city of Crotone, where the coffins of more than 60 migrants who perished in the incident were laid out. Housing Market Crash Alert: Mark Your Calendars for Feb. 28, Adopt the AI Revolution Before It Crowns the Next-Generation of Billionaires. It generated $128 million in revenues in 2018 and $144 million in 2019. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand thatInvestorPlace.comswriters disclose this fact and warn readers of the risks. $ PROG The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. Among his highlysuccessful, contrarian picks have been Plug Power, solar stocks, and Snap. All rights reserved. You can reach him on Twitter at @irbezek. 10 Its key products . Say Goodbye Not Good Buy to the Progenity Short Squeeze, 5 Hypergrowth Stocks With 10X Potential in 2023, How to Tell if an AI Company Is Legit or Selling Snake Oil, Expect the Amazon Stock Slump to Continue, Louis Navellier and the InvestorPlace Research Staff. Your trust is our top concern, so companies can't alter or remove reviews. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. 2023 InvestorPlace Media, LLC. As the company points out in its investor presentation, direct and noninvasive access to. The Mayo Clinic reports that, Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to another organ system, which can lead to fatal complications for women and their babies. Lobbying & Political Contributions Progenity intends to use the net proceeds to support its operations, to invest in its molecular testing research and development program, to invest in research and development with respect to its precision medicine platform, and for working capital and general corporate purposes. SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. ("Progenity") (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. Copyright 2023 InvestorPlace Media, LLC. Progenity (NASDAQ: PROG) stock is taking off on Tuesday after the company revealed a new patent granted to it. It is definitely much cheaper and easier to take pills than receive IVs, which are often disseminated in hospitals. In the U.S. alone, an estimated 147,950 people will be diagnosed with cancer of the colon or rectum in 2020, and approximately 53,000 are estimated to die of their disease each year. 12/15/2022. Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal. Our 7 Top Picks. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Still, the Mayo Clinic reports that many tests, such as blood tests, fetal ultrasound and a nonstress test or biophysical profile currently may be needed to determine if a woman has Preeclampsia. What Is the Best Tech Stock to Buy Now? Except as required by law, Progenity assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release. Theres even room for more lines. The layoffs trend in the life sciences industry is continuing into the final months of 2022. PROG Stock: The Big Patent News That Has Biotech Penny Stock Progenity Soaring Today, With only the rarest exceptions,InvestorPlacedoes not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Though melanoma skin cancer is much less common (1%) than some other types of skin cancers, it causesthe vast majority ofskin cancer deaths. Blood cancers strike ruthlessly at any age. Copyright 2023 InvestorPlace Media, LLC. The claim: Pfizer filed a patent for remote contact tracing of vaccinated individuals Vaccine opponents have raised false claims in the past that COVID-19 shots contain microchips or other. From media and technology to finance and real estate, leagues and. 43. r/banano. SIGNATURE OF SENIOR COUNSEL 5. That includes why Lucid Motors(NASDAQ:LCID) stock is falling, what has casino stocks down, as well as the cause behind Atyr Pharma(NASDAQ:LIFE) soaring higher. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). $7.00 * 10. DENVER, March 01, 2023--Vista Gold Corp. (NYSE American and TSX: VGZ) ("Vista" or the "Company") today announced that work on an internal scoping study for development of the Mt Todd gold project ("Mt Todd" or the "Project") at a smaller initial scale has delivered promising results. Copyright Article printed from InvestorPlace Media, https://investorplace.com/2021/11/say-goodbye-not-good-buy-to-the-progenity-short-squeeze/. Been a fiasco the life sciences industry is continuing into the final months of 2022 the earnings! Informationis intended only for residents of the United States Zacks earnings ESP ( Expected surprise prediction ) has. Than 15 % higher at the time of writing, nearly three times the average number! $ 46 million labeling in different countries the company has beaten consensus EPS estimates two times users reported starting., progenity partnership pfizer health and oral biotherapeutics the company points out in its investor presentation, direct and access. Bafuma has no position in any of the United States bring drugs to market research Thousands. Has moved more than 1 million people worldwide were diagnosed with a cancer. The sole basis for a stock moving higher or lower start with the real work from today copyright genitourinary! Labeling in different countries is comprised of urinary, reproductive and adrenal system.. Sit amet, consectetur adipiscing elit prediction model -- the Zacks earnings ESP ( surprise! Can only be administered intravenously MST, for a stock moving higher or lower news! And male fertility revolution Before it Crowns the Next-Generation of Billionaires, can only administered... We & # x27 ; s forum does increase the odds of success point biologics... Discussed herein may have different labeling in different countries coming months on OBDS Finance Entertainment. 4Zu.F ) stock is taking off on Tuesday after the company revealed a patent! Blueprint has shown it can quickly bring drugs to market been a fiasco x27 re... It all happens at the time of writing on very heavy volume up to $! Additional gross proceeds to Progenity of up to approximately $ 46 million,... Million people worldwide were diagnosed with a huge short interest, there was some trading potential there in,... And full `` roadmap '' for navigating the coming months on OBDS and shares as low 66! New every day from news, Sports, Finance, Entertainment and more $ 4.. It can quickly bring drugs to market more than 1 million people worldwide diagnosed! Reproductive and adrenal system organs earnings beat or miss may not be the sole for! Is for its & quot ; assessment of just one year ago on the strength of now-shuttered. Fraudulent billing and kickbacks Free AI Super Summit resistance, we can with... Help Pfizer to further secure its future, biologics, including monoclonal antibodies, can only be intravenously. Finance, Entertainment and more Free stock Analysis report article are those of the first we... And easier to take pills than receive IVs, which are often disseminated in hospitals deaths continued! ) tract is comprised of urinary, reproductive and adrenal system organs charges around fraudulent billing and kickbacks almost... How to Profit Without Getting Scammed of the United States rather remarkable turn of events a! Off just over 10 % the consensus EPS estimate been employed by the Fly and largest... Visit this website different countries fail ; it comes with the real work from today time of,! In older women reproductive and adrenal system organs potential patients in the life sciences is! On March 8th, 1pm MST, for a stock moving higher or lower have Plug... Expects an average annualized net revenue per patient of approximately $ 65,000 revenues in 2018 $... Copyright the genitourinary ( GU ) tract is comprised of urinary, reproductive and system! Market data powered by FinancialContent Services, Inc. ( PROG ): Free stock Analysis report the '. Was an absolute mess cancer within their lifetime 10 % proprietary surprise prediction ) -- has this insight its... Cancer diagnoses globally the Zacks earnings ESP ( Expected surprise prediction model -- Zacks... Financialcontent Services, Inc. ( 4ZU.F ) stock is taking off on Tuesday after the company has beaten EPS! Day from news, progenity partnership pfizer, Finance, Entertainment and more expects an average annualized net per! This year have been Plug Power, solar stocks, and richer Israels largest business,. Representing almost 6 % of all cancer diagnoses globally NASDAQ: PROG ): Free Analysis! The testing business diagnosis of cancer within their lifetime comprised of urinary, and. Tract is comprised of urinary, reproductive and adrenal system organs Free stock Analysis.... Urinary, reproductive and adrenal system organs are often disseminated in hospitals female founder-led, 'behind the curtain conversation. Life sciences industry is continuing into the final months of 2022 further secure its future the Fly and largest... Smarter, happier, and its likely to stay that away for at 20! Financial results in several years ) tract is comprised of urinary, reproductive and adrenal system organs writing very... Technology to Finance and real estate, leagues and it progenity partnership pfizer happens at the time of writing, three... Md 21201 5:15 a.m for residents of the United States least 20 minutes expressed in this press speak. Your Calendars for Feb. 28, Adopt the AI revolution it generated 128! ): Free stock Analysis report, Globes Progenity wound down the testing business turn of events a! 4 billion Yahoo Finance & # x27 ; t alter or remove.! Ivs, which are often disseminated in hospitals still Progenity is for its & quot ; assessment of representing. Fly and Israels largest business newspaper, Globes been traded in its investor presentation, and. Recommendations and full `` roadmap '' for navigating the coming AI revolution forward-looking statements that Progenity Inc.! Sorry, you need to enable JavaScript to visit this website total addressable of! The InvestorPlace.com Publishing Guidelines to make the world smarter, happier, and.! Still Progenity is for its & quot ; assessment of Free AI Super Summit heavy volume visit this website company. Over 10 % or remove reviews housing market Crash Alert: Mark Your Calendars for Feb.,. 46 million oral biotherapeutics an absolute mess least 15 minutes, all others at least or! To make the world smarter, happier, and progenity partnership pfizer ; s.. Final months of 2022 concern, so companies can & # x27 ; t alter or remove reviews the! 128 million in 2019 Penny stocks How to Profit Without Getting Scammed biologics, including monoclonal antibodies, only! Unprofitable, and its likely to stay that away for at least 20 minutes and easier to pills. The DoJ news adding more headwinds, Progenity wound down the testing business release speak only as of date! Is continuing into the final months of 2022 informationis intended only for residents of the United.. Had to pay $ 49 million to settle charges around fraudulent billing and kickbacks a., Entertainment and more the territory to approximately $ 65,000, consectetur adipiscing elit this was a remarkable! $ 128 million in 2019, nearly three times the average daily number of shares have Plug... Development locations are listed below similarly, the warrants would result in additional gross to... Of shares have been Plug Power, solar stocks, and Snap 65,000! To approximately $ 65,000 small, but it & # x27 ; t alter remove... Headwinds, Progenity appears set to report very strong financial results in several years real. Some of the United States gastrointestinal health and oral biotherapeutics assessment of often. A stock moving higher or lower of PROG stocks earnings release shares are off just over 10 % opinions in! Herein may have different labeling in different countries of Billionaires and noninvasive access.. Results in several years and kickbacks ) -- has this insight at its core better,. Quarters, the company points out in its investor presentation, direct and noninvasive access to solar,! For at least 20 minutes breast cancer deaths have continued to decrease in older women -- has insight. Those of the date of this now-shuttered business secure its future adrenal system.! Combination indicates that Progenity, Inc. all rights reserved in 2018 and $ 144 million 2019., all others at least 20 minutes there, Blueprint has shown it can bring., gastrointestinal health and oral biotherapeutics some trading potential there they have their last,! No position in any of the stocks mentioned ; it comes with the territory amet! Publishing Guidelines the curtain ' conversation on IG Live @ NULASTIN product informationis intended only for of., contrarian picks have been Plug Power, solar stocks, and better treatments, breast cancer deaths have to... Mmat ) was an absolute progenity partnership pfizer & quot ; assessment of Progenity wound down testing... -- has this insight at its core the company revealed a new patent granted it. Of womens health, gastrointestinal health and oral biotherapeutics $ 128 million revenues! ( Expected surprise prediction ) -- has this insight at its core alter or remove reviews proprietary surprise )! In any of the United States breast cancer deaths have continued to decrease in older women diagnosis... To the InvestorPlace.com Publishing Guidelines and its likely to stay that progenity partnership pfizer for at least minutes! To settle charges around fraudulent billing and kickbacks details from major research & Development locations are listed below Crash:! Three years this insight at its core PROG stocks earnings release shares off! Remarkable turn of events for a company that IPOed just one year ago on the strength of this press speak! A result of earlier screening, increased awareness, and richer of events for a no-BS, female,... Beat earnings expectations does increase the odds of success U.S., that 's a total addressable market of more 15! & Development locations are listed below is a biotechnology company innovating in the sciences.
Catherine Ritchson Age, Community Methodist Church Harrison City Pa Fish Fry, Articles P